Investigation of Electrocatalysis for Tiered-Tower Micro-Electro-Mechanical-Systems Biosensors: Applied to Early Prevention of Thrombosis Factor Trimethylamine N-Oxide
Wei-Cheng David Lin,Shang-Chun Chou,Wei-Lun Yen,Yun-Yu Hsieh,Chun-Ting Hsieh
DOI: https://doi.org/10.1039/d4nr02693d
IF: 6.7
2024-09-29
Nanoscale
Abstract:Trimethylamine N-Oxide (TMAO) metabolism has been recognized as a biomarker for early thrombosis detection. However, testing for TMAO typically requires expensive laboratory equipment and skilled technicians, making it unsuitable as a pre-screening device for home care. To enable widespread use in home applications, it is crucial to develop a scalable and sensitive device capable of catalyzing TMAO with a specific enzyme, tailored for point-of-care use. This study presents an investigation of a MEMS based two tiered-layer tower biosensor array with a detection limit of 0.1 μM for TMAO, aimed at diagnosing chronic metabolic diseases in urine or serum. Based on augmented Cole-Cole model, the proposed parameters R_catalyzed, C_catalyzed, and Rp_catalyzed in the model can predict the catalytic impedance of enzyme activities, such as the redox effects of analytes, and characterize the small signal current caused by catalysis. The proposed MEMS biosensor, integrated with readout circuitry, demonstrates high sensitivity of 41 ADC counts/μM TMAO (or 4.5 mV/μM TMAO), a response time of 1 second, a repetition rate of 98.9%, and a drift over time of 0.5 mV. The sensor effectively discriminates TMAO based on minute capacitance changes induced by the TorA enzyme, resulting in a discernible 10.6% distinction. These measurements have been successfully compared to the conventional cyclic-voltammetry (CV) method, showing a mere 0.024% variance. The proposed biosensor is well-suited for pre-screening thrombosis factors in early prevention for point-of-care applications. The device is cost-effective, lightweight, and demonstrates excellent performance, with an 88% conversion rate of TMAO and a 97% selectivity rate for the by-product TMA, allowing for the prediction of cardiovascular risk in advance.
materials science, multidisciplinary,physics, applied,nanoscience & nanotechnology,chemistry